Logo image of TMHC

TAYLOR MORRISON HOME CORP (TMHC) Stock Fundamental Analysis

USA - NYSE:TMHC - US87724P1066 - Common Stock

59.08 USD
-0.77 (-1.29%)
Last: 10/29/2025, 8:04:00 PM
59.08 USD
0 (0%)
After Hours: 10/29/2025, 8:04:00 PM
Fundamental Rating

6

Overall TMHC gets a fundamental rating of 6 out of 10. We evaluated TMHC against 61 industry peers in the Household Durables industry. Both the health and profitability get an excellent rating, making TMHC a very profitable company, without any liquidiy or solvency issues. TMHC scores decently on growth, while it is valued quite cheap. This could make an interesting combination. With these ratings, TMHC could be worth investigating further for value and quality investing!.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

TMHC had positive earnings in the past year.
TMHC had a positive operating cash flow in the past year.
TMHC had positive earnings in each of the past 5 years.
In the past 5 years TMHC always reported a positive cash flow from operatings.
TMHC Yearly Net Income VS EBIT VS OCF VS FCFTMHC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B

1.2 Ratios

TMHC's Return On Assets of 8.84% is fine compared to the rest of the industry. TMHC outperforms 72.13% of its industry peers.
TMHC has a better Return On Equity (13.76%) than 60.66% of its industry peers.
TMHC has a better Return On Invested Capital (10.86%) than 68.85% of its industry peers.
TMHC had an Average Return On Invested Capital over the past 3 years of 12.32%. This is in line with the industry average of 10.34%.
Industry RankSector Rank
ROA 8.84%
ROE 13.76%
ROIC 10.86%
ROA(3y)10.27%
ROA(5y)8.31%
ROE(3y)17.42%
ROE(5y)15.22%
ROIC(3y)12.32%
ROIC(5y)10.17%
TMHC Yearly ROA, ROE, ROICTMHC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

TMHC has a better Profit Margin (10.16%) than 83.61% of its industry peers.
In the last couple of years the Profit Margin of TMHC has grown nicely.
TMHC has a better Operating Margin (14.53%) than 86.89% of its industry peers.
In the last couple of years the Operating Margin of TMHC has grown nicely.
TMHC's Gross Margin of 23.91% is on the low side compared to the rest of the industry. TMHC is outperformed by 60.66% of its industry peers.
In the last couple of years the Gross Margin of TMHC has grown nicely.
Industry RankSector Rank
OM 14.53%
PM (TTM) 10.16%
GM 23.91%
OM growth 3Y8.83%
OM growth 5Y15.82%
PM growth 3Y6.96%
PM growth 5Y15.12%
GM growth 3Y5.68%
GM growth 5Y6.83%
TMHC Yearly Profit, Operating, Gross MarginsTMHC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20 25

7

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), TMHC is creating some value.
Compared to 1 year ago, TMHC has less shares outstanding
Compared to 5 years ago, TMHC has less shares outstanding
TMHC has a better debt/assets ratio than last year.
TMHC Yearly Shares OutstandingTMHC Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
TMHC Yearly Total Debt VS Total AssetsTMHC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2.2 Solvency

An Altman-Z score of 3.79 indicates that TMHC is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 3.79, TMHC is in the better half of the industry, outperforming 63.93% of the companies in the same industry.
TMHC has a debt to FCF ratio of 3.84. This is a good value and a sign of high solvency as TMHC would need 3.84 years to pay back of all of its debts.
The Debt to FCF ratio of TMHC (3.84) is better than 62.30% of its industry peers.
A Debt/Equity ratio of 0.35 indicates that TMHC is not too dependend on debt financing.
TMHC has a Debt to Equity ratio (0.35) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.35
Debt/FCF 3.84
Altman-Z 3.79
ROIC/WACC1.27
WACC8.53%
TMHC Yearly LT Debt VS Equity VS FCFTMHC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B

2.3 Liquidity

TMHC has a Current Ratio of 6.43. This indicates that TMHC is financially healthy and has no problem in meeting its short term obligations.
With an excellent Current ratio value of 6.43, TMHC belongs to the best of the industry, outperforming 80.33% of the companies in the same industry.
TMHC has a Quick Ratio of 6.43. This is a bad value and indicates that TMHC is not financially healthy enough and could expect problems in meeting its short term obligations.
TMHC has a Quick ratio of 0.58. This is in the lower half of the industry: TMHC underperforms 62.30% of its industry peers.
Industry RankSector Rank
Current Ratio 6.43
Quick Ratio 0.58
TMHC Yearly Current Assets VS Current LiabilitesTMHC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

5

3. Growth

3.1 Past

TMHC shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 8.21%, which is quite good.
The Earnings Per Share has been growing by 23.42% on average over the past years. This is a very strong growth
Looking at the last year, TMHC shows a small growth in Revenue. The Revenue has grown by 6.98% in the last year.
TMHC shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 11.39% yearly.
EPS 1Y (TTM)8.21%
EPS 3Y17.06%
EPS 5Y23.42%
EPS Q2Q%-15.19%
Revenue 1Y (TTM)6.98%
Revenue growth 3Y2.88%
Revenue growth 5Y11.39%
Sales Q2Q%-1.39%

3.2 Future

TMHC is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 3.88% yearly.
The Revenue is expected to grow by 0.75% on average over the next years.
EPS Next Y-1.88%
EPS Next 2Y-3.46%
EPS Next 3Y3.88%
EPS Next 5YN/A
Revenue Next Year1.56%
Revenue Next 2Y-1.84%
Revenue Next 3Y0.75%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
TMHC Yearly Revenue VS EstimatesTMHC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2B 4B 6B 8B
TMHC Yearly EPS VS EstimatesTMHC Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2 4 6 8

8

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 7.12 indicates a rather cheap valuation of TMHC.
86.89% of the companies in the same industry are more expensive than TMHC, based on the Price/Earnings ratio.
Compared to an average S&P500 Price/Earnings ratio of 26.76, TMHC is valued rather cheaply.
The Price/Forward Earnings ratio is 7.56, which indicates a rather cheap valuation of TMHC.
Compared to the rest of the industry, the Price/Forward Earnings ratio of TMHC indicates a rather cheap valuation: TMHC is cheaper than 90.16% of the companies listed in the same industry.
TMHC's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 22.63.
Industry RankSector Rank
PE 7.12
Fwd PE 7.56
TMHC Price Earnings VS Forward Price EarningsTMHC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, TMHC is valued a bit cheaper than the industry average as 77.05% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, TMHC is valued cheaply inside the industry as 80.33% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 10.25
EV/EBITDA 6.16
TMHC Per share dataTMHC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80

4.3 Compensation for Growth

The decent profitability rating of TMHC may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0.3
EPS Next 2Y-3.46%
EPS Next 3Y3.88%

0

5. Dividend

5.1 Amount

TMHC does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

TAYLOR MORRISON HOME CORP

NYSE:TMHC (10/29/2025, 8:04:00 PM)

After market: 59.08 0 (0%)

59.08

-0.77 (-1.29%)

Chartmill FA Rating
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryHousehold Durables
Earnings (Last)10-22 2025-10-22/bmo
Earnings (Next)02-10 2026-02-10/bmo
Inst Owners100.58%
Inst Owner Change0.66%
Ins Owners0.47%
Ins Owner Change-6.67%
Market Cap5.84B
Revenue(TTM)8.38B
Net Income(TTM)850.94M
Analysts82.5
Price Target74.93 (26.83%)
Short Float %3.81%
Short Ratio3.08
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-0.92%
Min EPS beat(2)-2.85%
Max EPS beat(2)1.01%
EPS beat(4)2
Avg EPS beat(4)0.19%
Min EPS beat(4)-5.59%
Max EPS beat(4)8.2%
EPS beat(8)5
Avg EPS beat(8)1.44%
EPS beat(12)7
Avg EPS beat(12)4.86%
EPS beat(16)11
Avg EPS beat(16)6.37%
Revenue beat(2)1
Avg Revenue beat(2)1.09%
Min Revenue beat(2)-2.35%
Max Revenue beat(2)4.54%
Revenue beat(4)3
Avg Revenue beat(4)1.14%
Min Revenue beat(4)-2.35%
Max Revenue beat(4)4.54%
Revenue beat(8)6
Avg Revenue beat(8)1.28%
Revenue beat(12)10
Avg Revenue beat(12)3.22%
Revenue beat(16)12
Avg Revenue beat(16)2.2%
PT rev (1m)0.49%
PT rev (3m)3.39%
EPS NQ rev (1m)0.22%
EPS NQ rev (3m)-6.11%
EPS NY rev (1m)0%
EPS NY rev (3m)-3.35%
Revenue NQ rev (1m)0.79%
Revenue NQ rev (3m)0.64%
Revenue NY rev (1m)0.42%
Revenue NY rev (3m)0.95%
Valuation
Industry RankSector Rank
PE 7.12
Fwd PE 7.56
P/S 0.7
P/FCF 10.25
P/OCF 9.59
P/B 0.94
P/tB 1.06
EV/EBITDA 6.16
EPS(TTM)8.3
EY14.05%
EPS(NY)7.82
Fwd EY13.23%
FCF(TTM)5.77
FCFY9.76%
OCF(TTM)6.16
OCFY10.43%
SpS84.77
BVpS62.57
TBVpS55.86
PEG (NY)N/A
PEG (5Y)0.3
Graham Number108.09
Profitability
Industry RankSector Rank
ROA 8.84%
ROE 13.76%
ROCE 14.26%
ROIC 10.86%
ROICexc 11.36%
ROICexgc 12.36%
OM 14.53%
PM (TTM) 10.16%
GM 23.91%
FCFM 6.8%
ROA(3y)10.27%
ROA(5y)8.31%
ROE(3y)17.42%
ROE(5y)15.22%
ROIC(3y)12.32%
ROIC(5y)10.17%
ROICexc(3y)13.54%
ROICexc(5y)11.21%
ROICexgc(3y)15.61%
ROICexgc(5y)12.91%
ROCE(3y)16.18%
ROCE(5y)13.35%
ROICexgc growth 3Y6.33%
ROICexgc growth 5Y16.78%
ROICexc growth 3Y6.48%
ROICexc growth 5Y14.62%
OM growth 3Y8.83%
OM growth 5Y15.82%
PM growth 3Y6.96%
PM growth 5Y15.12%
GM growth 3Y5.68%
GM growth 5Y6.83%
F-Score7
Asset Turnover0.87
Health
Industry RankSector Rank
Debt/Equity 0.35
Debt/FCF 3.84
Debt/EBITDA 1.74
Cap/Depr 100.08%
Cap/Sales 0.47%
Interest Coverage 250
Cash Conversion 48.49%
Profit Quality 66.97%
Current Ratio 6.43
Quick Ratio 0.58
Altman-Z 3.79
F-Score7
WACC8.53%
ROIC/WACC1.27
Cap/Depr(3y)92.93%
Cap/Depr(5y)86.63%
Cap/Sales(3y)0.42%
Cap/Sales(5y)0.43%
Profit Quality(3y)74.16%
Profit Quality(5y)144.41%
High Growth Momentum
Growth
EPS 1Y (TTM)8.21%
EPS 3Y17.06%
EPS 5Y23.42%
EPS Q2Q%-15.19%
EPS Next Y-1.88%
EPS Next 2Y-3.46%
EPS Next 3Y3.88%
EPS Next 5YN/A
Revenue 1Y (TTM)6.98%
Revenue growth 3Y2.88%
Revenue growth 5Y11.39%
Sales Q2Q%-1.39%
Revenue Next Year1.56%
Revenue Next 2Y-1.84%
Revenue Next 3Y0.75%
Revenue Next 5YN/A
EBIT growth 1Y4.7%
EBIT growth 3Y11.97%
EBIT growth 5Y29.02%
EBIT Next Year18.65%
EBIT Next 3Y4.41%
EBIT Next 5YN/A
FCF growth 1Y-50.16%
FCF growth 3Y-21.22%
FCF growth 5Y-13.71%
OCF growth 1Y-49.17%
OCF growth 3Y-17.68%
OCF growth 5Y-11.78%

TAYLOR MORRISON HOME CORP / TMHC FAQ

What is the ChartMill fundamental rating of TAYLOR MORRISON HOME CORP (TMHC) stock?

ChartMill assigns a fundamental rating of 6 / 10 to TMHC.


What is the valuation status of TAYLOR MORRISON HOME CORP (TMHC) stock?

ChartMill assigns a valuation rating of 8 / 10 to TAYLOR MORRISON HOME CORP (TMHC). This can be considered as Undervalued.


How profitable is TAYLOR MORRISON HOME CORP (TMHC) stock?

TAYLOR MORRISON HOME CORP (TMHC) has a profitability rating of 7 / 10.


What is the valuation of TAYLOR MORRISON HOME CORP based on its PE and PB ratios?

The Price/Earnings (PE) ratio for TAYLOR MORRISON HOME CORP (TMHC) is 7.12 and the Price/Book (PB) ratio is 0.94.


What is the financial health of TAYLOR MORRISON HOME CORP (TMHC) stock?

The financial health rating of TAYLOR MORRISON HOME CORP (TMHC) is 7 / 10.